Long non-coding RNA ENST00000503625 is a potential prognostic biomarker and metastasis suppressor gene in prostate cancer

[1] Batista PJ(2013)Long noncoding RNAs: cellular address codes in development and disease Cell 152 1298-1307

[2] Chang HY(2017)Long noncoding RNA and cancer: a new paradigm Cancer Res 77 3965-3981

[3] Bhan A(2020)The potential role for immunotherapy in biochemically recurrent prostate cancer Urol Clin North Am 47 457-467

[4] Soleimani M(2005)The University of California, san Francisco cancer of the prostate risk assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy J Urol 173 1938-1942

[5] Mandal SS(2008)Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer- specific mortality: evidence from the TROG 96.01 randomised controlled trial Lancet Oncol 9 1058-1068

[6] Bilusic M(2012)The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression Genome Res 22 1775-1789

[7] Einstein DJ(2009)The use of PCA3 in the diagnosis of prostate cancer Nat Rev Urol 6 255-261

[8] Karzai FH(2017)Technological developments in lncRNA biology Adv Exp Med Biol 1008 283-323

[9] Cooperberg MR(2021)High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity Neoplasia 23 634-641

[10] Pasta DJ(2013)Long noncoding RNAs: insights from biological features and functions to diseases Med Res Rev 33 517-553

[1] Batista PJ(2013)Long noncoding RNAs: cellular address codes in development and disease Cell 152 1298-1307

[2] Chang HY(2017)Long noncoding RNA and cancer: a new paradigm Cancer Res 77 3965-3981

[3] Bhan A(2020)The potential role for immunotherapy in biochemically recurrent prostate cancer Urol Clin North Am 47 457-467

[4] Soleimani M(2005)The University of California, san Francisco cancer of the prostate risk assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy J Urol 173 1938-1942

[5] Mandal SS(2008)Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer- specific mortality: evidence from the TROG 96.01 randomised controlled trial Lancet Oncol 9 1058-1068

[6] Bilusic M(2012)The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression Genome Res 22 1775-1789

[7] Einstein DJ(2009)The use of PCA3 in the diagnosis of prostate cancer Nat Rev Urol 6 255-261

[8] Karzai FH(2017)Technological developments in lncRNA biology Adv Exp Med Biol 1008 283-323

[9] Cooperberg MR(2021)High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity Neoplasia 23 634-641

[10] Pasta DJ(2013)Long noncoding RNAs: insights from biological features and functions to diseases Med Res Rev 33 517-553